Quest Diagnostics Investor Presentation — January 2020

Document content

Accelerating Growth,

Chairman, President and

Chief Executive Officer

38th Annual J.P. Morgan

Healthcare Conference

January 14, 20202SAFE HARBOR DISCLOSURE

The statements inthefollowing presentation that arenothistorical facts may beforward -looking

statements .Readers arecautioned nottoplace undue reliance onforward -looking statements, which

speak only asofthedate that they aremade and which reflect management’s current estimates,

projections, expectations orbeliefs and which involve risks and uncertainties that could cause actual

results andoutcomes tobematerially different .Risks anduncertainties thatmay affect thefuture results

ofthecompany include, butarenotlimited to,adverse results from pending orfuture government

investigations, lawsuits orprivate actions, thecompetitive environment, the complexity ofbilling,

reimbursement and revenue recognition forclinical laboratory testing, changes ingovernment

regulations, changing relationships with customers, payers, suppliers orstrategic partners and other

factors discussed inthecompany's most recently filed Annual Report onForm 10-Kandinanyofthe

company's subsequently filed Quarterly Reports onForm 10-Qand Current Reports onForm 8-K,

including those discussed inthe“Business,” “Risk Factors,” “Cautionary Factors thatMay Affect Future

Results” and“Management’s Discussion andAnalysis ofFinancial Condition andResults ofOperations”

sections ofthose reports .3

Quest plays a crucial role in driving health care’s “triple aim”

We have a sharp focus on

Medical Quality and Service

Quest delivers sizable

Superior experience:

Quest is becoming the lab of

choice for consumers5Healthier world : We have a sharp focus on Medical Quality and Service

for key metrics such as lost

specimens and missed pickups ~6,600+

Quest owns or controls

Preview truncated — download the full document for the complete content.